Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2021 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021

- Up to Approximately $113 Million of Oral TPOXX® Targeted for Delivery to the U.S. Government in the Fourth Quarter - - Approximately $13 Million of International Sales for the First Nine Months of...
October 28, 2021 16:15 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on November 4th, 2021, Following Release of Third Quarter 2021 Financial Results

NEW YORK, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
September 13, 2021 07:30 ET | Source: SIGA Technologies Inc.

SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX®

NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of a procurement option under its...
September 07, 2021 13:16 ET | Source: SIGA Technologies Inc.

SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021

NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Company’s Chief...
August 05, 2021 16:15 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021

- Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter – - Authorization of Additional $50 Million Share Repurchase Program - - Corporate Update Conference Call...
July 29, 2021 16:15 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
July 29, 2021 03:30 ET | Source: SIGA Technologies Inc.

SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
June 30, 2021 07:30 ET | Source: SIGA Technologies Inc.

SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom

NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...
May 06, 2021 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three Months Ended March 31, 2021

- Approximately $3 Million in International Sales of Oral TPOXX® in the First Quarter - - Approximately $7 Million in International Sales of Oral TPOXX® in April - - Corporate Update Conference...
May 04, 2021 07:30 ET | Source: SIGA Technologies Inc.

SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX

NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has...